Join
Live feed
·
INSIDERFilingvia Quantisnow
Finch Therapeutics Group Inc. logo

SEC Form 4: Blaustein Marc sold $5,054 worth of shares (3,636 units at $1.39), decreasing direct ownership by 10% to 32,614 units (for tax liability)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track FNCH (Finch Therapeutics Group Inc.) and more on Quantisnow.